Cardiovolt.ai

Details

Imperial College London spinout building AI-ECG software designed to read a standard ECG - one of the cheapest, most routine test in medicine - and flag which patients need further cardiac investigation; validated on 6M+ ECGs across four continents, with FDA 510(k) and EU MDR submissions targeted for Q1 2027.
Territory:
United Kingdom
Year Founded:
Links:
Company LinkedIn
Founder LinkedIn
https://cardiovolt.ai

Status

Raised Before:
Investors include:
Go Back